Scarica l'app Stockscreener
0.4601
11.65%
0.048
Dopo l'orario di chiusura:
.49
0.0299
+6.50%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché TNXP Giù?
Forum
Previsione
Frazionamento azionario
Tonix Pharmaceuticals Holding Corp Borsa (TNXP) Ultime notizie
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 21.8%What's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5%What's Next? - MarketBeat
StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 22.4% HigherWhat's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 13.2%Should You Buy? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 7.6%Should You Buy? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 13.2%Here's Why - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 7.6%Should You Buy? - MarketBeat
Tonix Pharmaceuticals Holding (LTS:0A4T) Liabilities-to-Ass - GuruFocus.com
Tonix Pharmaceuticals Holding (LTS:0A4T) Price-to-Operating-Cash-Flow : (As of Jan. 17, 2025) - GuruFocus.com
FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL - MSN
Tonix Pharmaceuticals Holding (LTS:0A4T) Net Income : $-135.25 Mil (TTM As of Sep. 2024) - GuruFocus.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Tonix Pharmaceuticals Holding (LTS:0A4T) Altman Z-Score : -14.06 (As of Jan. 16, 2025) - GuruFocus.com
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals Holding (LTS:0A4T) 9-Day RSI : N/A (As of Jan. 15, 2025) - GuruFocus.com
Rivoluzionare la salute con i virus? Una nuova era per le scoperte biotecnologiche - Be3
(TNXP)Analyzing Tonix Pharmaceuticals's Short Interest - Benzinga
Revolutionizing Health with Viruses? A New Age for Biotech Breakthroughs - Be3
Tonix Pharmaceuticals Further Strengthens Commercial - GlobeNewswire
Tonix Pharma Announces Key Appointment and Study Timelines - TipRanks
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access - The Manila Times
Tonix Pharmaceuticals Strengthens Commercial Team Ahead of Critical FDA Decision on Fibromyalgia Drug - StockTitan
Tonix Is A Buy For Potentially Great Return On PTSD Breakthrough, Part 2 (NASDAQ:TNXP) - Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.2%Time to Sell? - MarketBeat
Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase Transcript - GuruFocus.com
Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences - The Manila Times
Tonix Pharmaceuticals CEO to Present Pipeline Updates at Major Neuroscience and Biotech Forums - StockTitan
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 2.5%Time to Buy? - MarketBeat
SABBY MANAGEMENT, LLC Acquires 1,306,313 Shares in Tonix Pharmaceuticals Holding Corp - GuruFocus.com
What’s Next for TNXP? The Future of Biotech and Stock Surges - Be3
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.5%What's Next? - MarketBeat
Tonix Receives PDUFA Goal Date for Sleep-Enhancing Fibromyalgia Drug Candidate - Sleep Review
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.5%What's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 8.4%Time to Sell? - MarketBeat
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024 - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by StockNews.com - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.8%Should You Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 5.3%What's Next? - MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.7%Time to Sell? - MarketBeat
This Micro Cap Is Getting Bid Up Prior To Opening Bell - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 2.6%Should You Sell? - MarketBeat
Certain Options of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Certain Warrants of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.4%Time to Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2%What's Next? - MarketBeat
FDA sets review goal date for Tonix fibromyalgia drug By Investing.com - Investing.com South Africa
0.35%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):